Yun-peng N. Liu

201 Hubin South Road
Xiamen, 361004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

Targeted Therapy and Immunotherapy in Elderly Patients with Metastatic Colorectal Cancer.

Targeted Therapy and Immunotherapy in Elderly Patients with Metastatic Colorectal Cancer.

Journal: Current treatment options in oncology

Published: April 15, 2025

Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial.

Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial.

Journal: Gut

Published: April 02, 2025

Recovery of enterogenic sepsis-induced disseminated intravascular coagulation after radical surgery for colon cancer: a case report

Recovery of enterogenic sepsis-induced disseminated intravascular coagulation after radical surgery for colon cancer: a case report

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: March 03, 2025

Albumin, the role beyond fluid resuscitation

Albumin, the role beyond fluid resuscitation

Journal: Zhonghua nei ke za zhi

Published: May 08, 2024

T-bet+CD8+ T cells govern anti-PD-1 responses in microsatellite-stable gastric cancers.

T-bet+CD8+ T cells govern anti-PD-1 responses in microsatellite-stable gastric cancers.

Journal: Nature communications

Published: April 25, 2024

The precision medicine for the treatment of acute respiratory distress syndrome is based on identification of phenotypes

The precision medicine for the treatment of acute respiratory distress syndrome is based on identification of phenotypes

Journal: Zhonghua yi xue za zhi

Published: April 18, 2024

Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study.

Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study.

Journal: BMC cancer

Published: January 22, 2024

Hypoxia-induced LAMB2-enriched extracellular vesicles promote peritoneal metastasis in gastric cancer via the ROCK1-CAV1-Rab11 axis.

Hypoxia-induced LAMB2-enriched extracellular vesicles promote peritoneal metastasis in gastric cancer via the ROCK1-CAV1-Rab11 axis.

Journal: Oncogene

Published: November 26, 2023

Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study.

Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study.

Journal: Journal of cancer research and clinical oncology

Published: April 14, 2023

Correction to: Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex.

Correction to: Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 08, 2021

Corrigendum: DYNC1I1 Promotes the Proliferation and Migration of Gastric Cancer by Up-Regulating IL-6 Expression.

Corrigendum: DYNC1I1 Promotes the Proliferation and Migration of Gastric Cancer by Up-Regulating IL-6 Expression.

Journal: Frontiers in oncology

Published: November 21, 2021

SOX8 promotes cetuximab resistance via HGF/MET bypass pathway activation in colorectal cancer.

SOX8 promotes cetuximab resistance via HGF/MET bypass pathway activation in colorectal cancer.

Journal: Cancer chemotherapy and pharmacology

Published: August 16, 2021

Showing 1-12 of 79

Last Updated: 09/26/2026